We are excited to announce that Nintx, a pioneering startup founded in Brazil in early 2021, has successfully raised $10 million in its latest funding round. This capital infusion will significantly accelerate our mission to translate complex biological interactions between plants and microorganisms into innovative therapies for multifactorial diseases. Founded by two accomplished PhDs, Dr. Miller Freitas (CEO) and Dr. Cristiano Guimarães (CSO), along with seasoned healthcare veteran Mr. Stephani Saverio, Nintx is positioned at the forefront of biotechnological advancements. Our unique approach focuses on harnessing Brazil’s rich biodiversity to unlock the potential of plant-based natural products, establishing them as a groundbreaking platform for modulating human biological targets and the microbiome. Notably, our proprietary technologies, including xGIbiomics®, which emulates the human digestive system, and GAIApath®, an AI-powered analytics tool for identifying potential therapeutic plants, are integral to our strategy. With this substantial funding, we will enhance our research and development capabilities, expanding our pipeline of multi-target therapies designed to effectively address complex ailments. As we embark on this exciting new chapter, we remain committed to innovation and scientific excellence, aiming to make a lasting impact on healthcare and improve patient outcomes globally. Thank you to our investors, partners, and the Nintx team for their unwavering support and belief in our vision. Together, we are poised to revolutionize the future of therapeutics.
Nintx Secures $10 Million in Series A Funding to Revolutionize Multi-Target Therapies with Brazilian Biodiversity
Recently funded · $10.0M Series aBiotechnology
Get the full Nintx company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
